Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Clasificación en acciones #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Precio por acción
$71.40
Capitalización bursátil
$29.93B
Cambio (1 día)
-0.13%
Cambio (1 año)
-51.06%
País
US
Comercio Zoetis Inc. (ZTS)

Categoría

Healthcare
Ganancias de Zoetis Inc. (ZTS)
Ganancias en Jun 2026 TTM: $3.27B
Secondo gli ultimi rapporti finanziari di Zoetis Inc., gli utili attuali della società sono $3.27B. Nel 2024, la società ha registrato un utile di $3.13B, un aumento con respecto a agli utili del 2023, che erano di $2.94B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Zoetis Inc. desde 2009 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $3.27B -2.62%
2025 $3.36B 7.25%
2024 $3.13B 6.71%
2023 $2.94B 10.54%
2022 $2.66B 6.75%
2021 $2.49B 24.65%
2020 $2.00B 10.83%
2019 $1.80B 6.57%
2018 $1.69B 10.82%
2017 $1.53B 24.19%
2016 $1.23B 125.32%
2015 $545.00M -33.54%
2014 $820.00M 18.84%
2013 $690.00M -2.82%
2012 $710.00M 80.20%
2011 $394.00M 121.35%
2010 $178.00M -220.27%
2009 $-148.00M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B 926.72%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B 670.05%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B 165.86%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B 553.68%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B 81.78%
US